IMAYZI Trademark

Trademark Overview

On Tuesday, October 26, 2021, a trademark application was filed for IMAYZI with the United States Patent and Trademark Office. The USPTO has given the IMAYZI trademark a serial number of 97093019. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 18, 2024. This trademark is owned by Bausch + Lomb Ireland Limited. The IMAYZI trademark is filed in the Pharmaceutical Products category with the following description:

ophthalmic pharmaceutical substances and preparations for the treatment of ocular diseases and disorders
imayzi

General Information

Serial Number97093019
Word MarkIMAYZI
Filing DateTuesday, October 26, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 18, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 21, 2022

Trademark Statements

Goods and Servicesophthalmic pharmaceutical substances and preparations for the treatment of ocular diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 9, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBausch + Lomb Ireland Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDublin 24
IE
Party NameBausch + Lomb Ireland Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDublin 24
IE

Trademark Events

Event DateEvent Description
Monday, March 18, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 18, 2024ABANDONMENT - NO USE STATEMENT FILED
Thursday, August 10, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 8, 2023SOU EXTENSION 2 GRANTED
Tuesday, August 8, 2023SOU EXTENSION 2 FILED
Tuesday, August 8, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, June 6, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 6, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 6, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, January 28, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 26, 2023SOU EXTENSION 1 GRANTED
Thursday, January 26, 2023SOU EXTENSION 1 FILED
Thursday, January 26, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, December 21, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, December 14, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, August 16, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 21, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 21, 2022PUBLISHED FOR OPPOSITION
Wednesday, June 1, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, May 18, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 18, 2022ASSIGNED TO EXAMINER
Tuesday, November 9, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 29, 2021NEW APPLICATION ENTERED

Related Keywords

imayzi ocular diseases disorders treatment preparations pharmaceutical substances ophthalmic